Free shipping on all orders over $ 500

 About 1 result found for searched term "845816-02-6" (0.124 seconds)

Cat.No.  Name Target
M25256 Lexatumumab Apoptosis
HGS-ETR 2 ETR2-ST01 Anti-Human ERBB3 Recombinant Antibody
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.